BlackRock trims total Kion voting rights to 3.66% from 3.95%
Reuters2026/08/11 14:01- BlackRock cut its total stake in Kion to 3.66% from 3.95%, a filing dated Aug. 11 showed.
- Voting rights from shares rose to 3.03% from 2.95%.
- Voting rights through instruments fell to 0.63% from 1%, mainly via Contract for Difference positions.
- The disclosure followed a threshold event dated Aug. 6.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Spot bitcoin ETFs pull in $987 million last week as institutional demand recovers
Silver Price Forecast: XAG/USD dips below $66.00 and hints at a bearish “H&S”
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well
Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.
